Clinical significance of pAkt and pErk1/2 expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

The expression of phosphorylated Akt (pAkt) and phosphorylated extracellular-regulated kinase 1/2 (pErk1/2) proteins may result in breast cancer progression and drug resistance in vitro, however, compelling evidence regarding the clinical significance of pAkt and pErk1/2 in early-stage breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, WENJUAN, ZHANG, LINGYUN, SHI, JING, LIU, YUNPENG, ZHOU, LIZHONG, HOU, KEZUO, QU, XIUJUAN, TENG, YUEE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356398/
https://www.ncbi.nlm.nih.gov/pubmed/25789027
http://dx.doi.org/10.3892/ol.2015.2965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356398/
https://www.ncbi.nlm.nih.gov/pubmed/25789027
http://dx.doi.org/10.3892/ol.2015.2965

Ejemplares similares